• Follow the Money: Universal Flu Vaccine, Full-Length Single-Molecule Protein Sequencer, More

    Bio-IT World | Centivax plans to get their first universal flu vaccine through a Phase I clinical trial; Portal Biotech will use their nanopore-based platform technology to deliver rapid, full-length, single-molecule protein characterization and expand its R&D, engineering, and data-science teams; and more.

    Jul 30, 2025

  • Arab Pangenome Reference Published

    Bio-IT World | Researchers have published the first draft Arab pangenome reference, the UAE Pangenome Reference (UPR) based on 53 individuals of diverse Arab ethnicities residing in the United Arab Emirates. The work was done at the Center for Applied and Translational Genomics (CATG), Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates and was published in Nature Communications last week.

    Jul 29, 2025

  • Multiomics Platform Integration Advances Cancer Treatment Predictions

    Bio-IT World | A groundbreaking biotech collaboration in Switzerland has successfully integrated nine molecular analysis platforms to create a comprehensive tumor profiling system that predicts optimal cancer treatments—showcasing how next-generation sequencing can be enhanced through multiomics approaches for transformative clinical outcomes.

    Jul 24, 2025

  • Innovative Practices Award for NHS England, IQVIA Privacy Protection Platform

    Bio-IT World | To support patient privacy while providing data accessibility for organizations, the National Health Service (NHS) England with IQVIA developed NHS PET (Privacy Enhancing Technology) as a secure, scalable solution for patient data. The work earned NHS and IQVIA one of four Innovative Practices Awards at this year’s Bio-IT World Conference & Expo—an honor the judges christened the “Respect the Patient Award”.

    Jul 23, 2025

  • NIST Releases First Cancer Cell Line for Public Genomic Research

    Bio-IT World | The National Institute of Standards and Technology (NIST) has released the first cancer cell line in its Genome in a Bottle (GIAB) consortium. The new resource features a pancreatic cancer tumor cell line along with corresponding normal tissue samples, all obtained with explicit patient consent for public genomic data sharing.

    Jul 22, 2025

  • The New Frontier in Alzheimer’s Prevention: AI-Powered Neurodiagnostic Solutions

    Bio-IT World | Imagine sitting down for a routine checkup and learning you could prevent one of the most devastating diseases of our time before it ever occurs. For many families, diagnosis arrives only after noticeable confusion or memory loss disrupts daily life. By that point, much of the brain has already been damaged, and options for slowing decline are limited.

    Jul 18, 2025

  • A Popular Alzheimer’s Biomarker Found at High Levels in Newborns

    Bio-IT World | In recent years, phosphorylated tau has garnered so much attention as one of the “bad guys” of Alzheimer’s disease that the scientific community may have developed a bit of tunnel vision. A medical doctor in Sweden seeks to remedy the situation as a “champion” of the biomarker based on the critical if forgotten physiological role it plays in the healthy human brain.

    Jul 16, 2025

  • Pharma Companies Finding Their Way with AI

    Bio-IT World | Massive progress has been enabled by individual applications of artificial intelligence (AI) and machine learning (ML) in drug discovery, AlphaFold being one of the most prominent, due to their ability to predict the type of molecules that should have a positive impact on patient care.

    Jul 15, 2025

  • Trends from the Trenches: What a TV Scientist Knows About Teaching Science

    Bio-IT World | David Hewlett, renowned for portraying Dr. Rodney McKay in the Stargate franchise, recently joined Trends from the Trenches podcast to discuss the fascinating intersection of Hollywood, science communication, and lifelong learning. Hewlett and host Ari Berman explore how entertainment can serve as a powerful gateway to scientific curiosity and innovation.

    Jul 10, 2025

  • From Physics to Longevity: How Gero’s ProtoBind-Diff Tool Reads Nature’s Hidden Drug Library

    Bio-IT World | Consumer genomics pioneer 23andMe will be returning to its co-founder and former CEO as Anne Wojcicki’s TTAM Research Institute outbids Regeneron to buy 23andMe out of bankruptcy—as long as no more state attorneys general object. The current iteration of the sale is expected to close on July 8.

    Jul 9, 2025

  • Population Genomics Projects Around the World Gaining Ground

    Bio-IT World | Pangaea Data has entered into a collaboration agreement with Alexion to develop an Artificial Intelligence Clinical Decision Support System; Dell Technologies will develop NERSC-10, the next flagship supercomputer at the National Energy Research Scientific Computing Center; and more.

    Jul 8, 2025

  • Virtual Cell Challenge Announces Prize for AI Models of Cellular Response

    Bio-IT World | In a commentary published last week in Cell, researchers from the Arc Institute introduced the “Virtual Cell Challenge,” a public competition with a grand prize worth $100,000 for the machine learning model that best predicts how cells will respond to genetic perturbations.

    Jul 3, 2025

  • Anne Wojcicki Buys Back 23andMe for $305M, Promises Data Security

    Bio-IT World | Consumer genomics pioneer 23andMe will be returning to its co-founder and former CEO as Anne Wojcicki’s TTAM Research Institute outbids Regeneron to buy 23andMe out of bankruptcy—as long as no more state attorneys general object. The current iteration of the sale is expected to close on July 8.

    Jul 2, 2025

  • Real-Time Drug Monitoring: A New Era for Drug Discovery and Development

    Bio-IT World | In Stanford University's engineering labs, Tom Soh has been wrestling with a paradox that has plagued medicine for decades. While modern jet engines generate terabytes of data every hour to prevent catastrophic failures, the human body gets monitored only during annual checkups or after something has already gone wrong.

    Jul 1, 2025

  • UK Study Demonstrates Real-World Value of Genetic Testing for Drug Prescribing

    Bio-IT World | The UK's National Health Service is pioneering a new approach to precision medicine through pharmacogenomic testing that could transform how doctors prescribe medications and significantly reduce healthcare costs. Early results from the NHS PROGRESS trial suggest that genetic testing can guide prescribing decisions for nearly all patients, with one in four participants having their prescriptions adjusted for safer or more effective treatment.

    Jun 26, 2025

  • Follow the Money: ITM’s Gastroenteropancreatic Therapy, GRIN, Angelini Pharma Collaborates, More

    Bio-IT World | ITM plans to use their financing to prepare for commercial readiness and potential market launch of the company’s lead candidate, n.c.a. 177Lu-edotreotide, which treats gastroenteropancreatic neuroendocrine tumors; GRIN and Angelini Pharma will develop and expand commercial rights outside of North America for GRIN's investigational drug radiprodil, which treats rare genetic epilepsies and neurodevelopmental disorders; and more.

    Jun 25, 2025

  • Pangaea Data, Alexion Collaboration, Dell to Develop Supercomputer, More

    Bio-IT World | Pangaea Data has entered into a collaboration agreement with Alexion to develop an Artificial Intelligence Clinical Decision Support System; Dell Technologies will develop NERSC-10, the next flagship supercomputer at the National Energy Research Scientific Computing Center; and more.

    Jun 24, 2025

  • Nanoneedle Patch Enables Non-Invasive Tissue Sampling Offering Spatiotemporal Insights

    Bio-IT World | Nanoneedle technology developed by researchers from King’s College London offers the ability to extract molecular information from living tissue without damaging or killing cells—offering spatial and longitudinal molecular insights that is described as a “fundamental scientific breakthrough.”

    Jun 19, 2025

  • Black Swan Initiative: Multi-Pronged Research Strategy Targets Multiple Myeloma Cure

    Bio-IT World | The International Myeloma Foundation's ambitious Black Swan Research Initiative is orchestrating a global collaborative effort to achieve what has long eluded researchers: a true cure for multiple myeloma. Through research partnerships spanning five continents, the initiative is systematically testing multiple therapeutic approaches while revolutionizing how cancer drug approvals are evaluated.

    Jun 18, 2025

  • Pistoia Alliance’s FAIR Maturity Assessment Tool

    Bio-IT World | Findable, Accessible, Interoperable and Reusable (FAIR) principles continue to hold an important place in data management and access, artificial intelligence (AI) and machine learning (ML) development, and data sharing between organizations. But FAIR is also complex to implement due to the original FAIR guidelines not being explicit and difficult to understand or visualize for non-experts. The FAIR community of experts with the Pistoia Alliance developed a self-assessment tool that can measure an organization’s FAIR maturity level.

    Jun 17, 2025